1-9 of 9
Angus G. Dalgleish
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Abstract 2582: Cytotopic IL-15 as a novel therapeutic for prostate cancer

Dorota A. Smolarek, Christina A. Sakellariou, Oussama Elhage, Osamu Ukimura, Inderbir Gill, Angus G. Dalgleish, Prokar Dasgupta, Richard A. G. Smith, Christine Galustian
Journal: Cancer Research
Cancer Res (2014) 74 (19_Supplement): 2582.
https://doi.org/10.1158/1538-7445.AM2014-2582
Published: 01 October 2014
View article titled, Abstract 2582: Cytotopic IL-15 as a novel therapeutic for prostate cancer
Journal Articles

Abstract 4233: The protein ps20 increases resistance to docetaxel in PC3 and LNCAP prostate cancer cell lines

Christine Galustian, Oliver Hickman, Richard A.G. Smith, Angus G. Dalgleish, Osamu Ukimura, Indebir S. Gill, Annapurna Vyakarnam, Prokar Dasgupta
Journal: Cancer Research
Cancer Res (2012) 72 (8_Supplement): 4233.
https://doi.org/10.1158/1538-7445.AM2012-4233
Published: 15 April 2012
View article titled, Abstract 4233: The protein ps20 increases resistance to docetaxel in PC3 and LNCAP prostate cancer cell lines
Journal Articles

Abstract 2833: The protein ps20 increases tumourigenic potential in prostate cancer epithelial cells

Oliver Hickman, Annapurna Vyakarnam, Richard A.G. Smith, Angus G. Dalgleish, Prokar Dasgupta, Christine Galustian
Journal: Cancer Research
Cancer Res (2012) 72 (8_Supplement): 2833.
https://doi.org/10.1158/1538-7445.AM2012-2833
Published: 15 April 2012
View article titled, Abstract 2833: The protein ps20 increases tumourigenic potential in prostate cancer epithelial cells
Journal Articles

Abstract 5386: Lenalidomide enhances the anti-prostate cancer activity of docetaxel in vitro and in vivo

Jake Y. Henry, Ling Lu, Mary Adams, Brendan Meyer, Blake Bartlett, Angus G. Dalgleish, Christine Galustian
Journal: Cancer Research
Cancer Res (2010) 70 (8_Supplement): 5386.
https://doi.org/10.1158/1538-7445.AM10-5386
Published: 15 April 2010
View article titled, Abstract 5386: Lenalidomide enhances the anti-prostate cancer activity of docetaxel <em>in vitro</em> and <em>in vivo</em>
Journal Articles

Abstract 5612: Pretreatment with chemotherapy can enhance the immunogenicity of tumors by promoting adaptive immune responses

Wai M. Liu, Daniel W. Fowler, Peter Smith, Angus G. Dalgleish
Journal: Cancer Research
Cancer Res (2010) 70 (8_Supplement): 5612.
https://doi.org/10.1158/1538-7445.AM10-5612
Published: 15 April 2010
View article titled, Abstract 5612: Pretreatment with chemotherapy can enhance the immunogenicity of tumors by promoting adaptive immune responses
Journal Articles

Abstract 5418: The immunomodulatory drug lenalidomide restores a Vitamin D sensitive phenotype to the Vitamin D resistant breast cancer cell line MDA-MB-231: Potential for breast cancer therapeutics

Carole Brosseau, Kay Colston, Blake Bartlett, Angus G. Dalgleish, Christine Galustian
Journal: Cancer Research
Cancer Res (2010) 70 (8_Supplement): 5418.
https://doi.org/10.1158/1538-7445.AM10-5418
Published: 15 April 2010
View article titled, Abstract 5418: The immunomodulatory drug lenalidomide restores a Vitamin D sensitive phenotype to the Vitamin D resistant breast cancer cell line MDA-MB-231: Potential for breast cancer therapeutics
Journal Articles

Lenalidomide (Revlimid®, CC-5013) and Actimid™ (CC-4047) inhibit the function and expansion of T regulatory (Treg) cells in vitro: Implications for anti-tumor activity in vivo

Christine Galustian, Deborah C. Klaschka, Brendan Meyer, Marie-Christine Labarthe, J. Blake Bartlett, Angus G. Dalgleish
Journal: Cancer Research
Cancer Res (2006) 66 (8_Supplement): 1147.
Published: 15 April 2006
View article titled, Lenalidomide (Revlimid®, CC-5013) and Actimid™ (CC-4047) inhibit the function and expansion of T regulatory (Treg) cells in vitro: Implications for anti-tumor activity in vivo
Journal Articles

Differential regulation of signalling pathways by 9-cis RA and EB1089 in pancreatic cancer cells

Petros X. E. Mouratidis, Angus G. Dalgleish, Kay W. Colston
Journal: Cancer Research
Cancer Res (2005) 65 (9_Supplement): 630–631.
Published: 01 May 2005
View article titled, Differential regulation of signalling pathways by 9-cis RA and EB1089 in pancreatic cancer cells
Journal Articles

A Novel Subclass of Thalidomide Analogue with Anti-Solid Tumor Activity in Which Caspase-dependent Apoptosis is Associated with Altered Expression of bcl-2 Family Proteins

J. Blake Marriott, Ian A. Clarke, Anna Czajka, Keith Dredge, Kay Childs, Hon-Wah Man, Peter Schafer, Sowmya Govinda, George W. Muller, David I. Stirling, Angus G. Dalgleish
Journal: Cancer Research
Cancer Res (2003) 63 (3): 593–599.
Published: 01 February 2003
View article titled, A Novel Subclass of Thalidomide Analogue with Anti-Solid Tumor Activity in Which Caspase-dependent Apoptosis is Associated with Altered Expression of bcl-2 Family Proteins
Open the PDF for A Novel Subclass of Thalidomide Analogue with Anti-Solid Tumor Activity in Which Caspase-dependent Apoptosis is Associated with Altered Expression of bcl-2 Family Proteins in another window